Thursday’s are for good quotes & coffee. Already had coffee so here’s one of my favorite quotes:
“Be so good, they CANT ignore you”
-Steve Martin
In your greatest achievement, think of the effort you put in to get to that result. Make that EFFORT your new work ethic standard
@kainvests Happy for you, us, and the whole $IOVA community. Too many catalysts still in play. Knowing Wayne is in at $9 means he’s not taking a BO at $12-17. He wants a double if not more. Cash runway is strong and if NSCLC gets approved, this will become a Gong show!!
@BrettErmilio SP stability has been nice so far. This is likely a big reason. $6 is now my new threshold for more shares. Anything under $6 and I’m jumping in more.
@Ashton_1nvests Ya but we got diluted twice. I’m a fan of the company and think Noto is awesome but there is an arguement for the time value of money to be spent elsewhere for a greater return.
@kainvests@IovanceBio Setttttling in just fine. Just so happy for this great company and the community of investors who believed in the product and technology. Now WE watch it grow!
@Vonti10toes@josephperson If Bryce is not the QB1 and future of the panthers, you can’t keep him on the roster. He also needs a new contract. What do you pay a QB2 ? He’s such a likeable guy but IF (because I’m rooting for him) he doesn’t stay, we will use that $ to bolster the current roster
@Futurenvesting@anthonynoto Sofi is going to be a great 2027 stock. For now we must ride the wave of manipulation. Let Noto continue to cook and block out the noise. Happy to keep writing CCs and investing back into the company.
@Henry431171040@BiotechXGuru No doubt NSCLC is the largest catalyst that exists for IOVA. But in comparison to SP right now, $IOVA Q2 ER is > than a REPL rejection.
$IOVA flirting with going under $4 as we head into Q2 earnings. The story hasn’t changed and neither have the shorts and the $XBI macro pullback. Stay the course, Fred will put proof in the pudding in early August.